Molecular Mechanisms and Therapeutic Effects of Drugs in Cancer—2nd Edition

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 1240

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland
Interests: carcinogenesis; gene expression regulation; molecular mechanisms; transcription factors
Special Issues, Collections and Topics in MDPI journals

E-Mail Website1 Website2
Guest Editor
1. Department of Biomedicine and Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland
2. Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland
Interests: cancer; neurology; in vitro; genetics; transcription factors
Special Issues, Collections and Topics in MDPI journals
1. Department of Biomedicine and Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland
2. Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland
Interests: carcinogenesis, functional genomics; high-throughput sequencing; in silico; transcription factors
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

With the first volume of this Special Issue being a great success (https://www.mdpi.com/journal/life/special_issues/Therapeutic_Effect), we are very pleased to announce the second volume of our Special Issue titled “Molecular Mechanisms and Therapeutic Effects of Drugs in Cancer—2nd Edition”. Despite significant progress in diagnosis and treatment, cancer remains the biggest challenge of modern medicine. The rapid advancement in molecular technologies and new sophisticated bioinformatic analytic methods have introduced novel therapeutic perspectives. This fuels hope for overcoming the major issues associated with drug treatment, such as cancer heterogeneity or multidrug resistance. We cordially invite you to present your outstanding cancer-drug-related discoveries in this Special Issue to the wider scientific and academic community.

In this Special Issue, we would like to present a collection of articles, such as reviews and systematic reviews, original papers, clinical trials, molecular and bioinformatics studies.

We are looking forward to your submission.

Dr. Elżbieta Janina Płuciennik
Dr. Żaneta Kałuzińska-Kołat
Dr. Damian Kołat
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • therapy
  • cancer drug
  • molecular mechanism
  • signaling pathways
  • targeted therapy
  • in silico drug response studies
  • innovative cancer treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

33 pages, 1782 KiB  
Review
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
by Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić and Milica Pešić
Life 2024, 14(9), 1142; https://doi.org/10.3390/life14091142 - 10 Sep 2024
Viewed by 898
Abstract
The field of oncology has witnessed remarkable progress in personalized cancer therapy. Functional precision medicine has emerged as a promising avenue for achieving superior treatment outcomes by integrating omics profiling and sensitivity testing of patient-derived cancer cells. This review paper provides an in-depth [...] Read more.
The field of oncology has witnessed remarkable progress in personalized cancer therapy. Functional precision medicine has emerged as a promising avenue for achieving superior treatment outcomes by integrating omics profiling and sensitivity testing of patient-derived cancer cells. This review paper provides an in-depth analysis of the evolution of cancer-directed drugs, resistance mechanisms, and the role of functional precision medicine platforms in revolutionizing individualized treatment strategies. Using two-dimensional (2D) and three-dimensional (3D) cell cultures, patient-derived xenograft (PDX) models, and advanced functional assays has significantly improved our understanding of tumor behavior and drug response. This progress will lead to identifying more effective treatments for more patients. Considering the limited eligibility of patients based on a genome-targeted approach for receiving targeted therapy, functional precision medicine provides unprecedented opportunities for customizing medical interventions according to individual patient traits and individual drug responses. This review delineates the current landscape, explores limitations, and presents future perspectives to inspire ongoing advancements in functional precision medicine for personalized cancer therapy. Full article
Show Figures

Figure 1

Back to TopTop